HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

João A Oliveira-da-Silva Selected Research

Pyridoxal Kinase

12/2020Corrigendum to "Leishmania infantum pyridoxal kinase evaluated in a recombinant protein and DNA vaccine to protects against visceral leishmaniasis". Molecular Immunology 124 (2020) 161-171.
1/2020Leishmania infantum pyridoxal kinase evaluated in a recombinant protein and DNA vaccine to protects against visceral leishmaniasis.
1/2020Evaluation of Leishmania infantum pyridoxal kinase protein for the diagnosis of human and canine visceral leishmaniasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


João A Oliveira-da-Silva Research Topics

Disease

26Visceral Leishmaniasis (Kala Azar)
06/2022 - 12/2019
14Infections
07/2022 - 01/2020
9Leishmaniasis
06/2022 - 12/2019
4Coinfection
12/2021 - 01/2020
2HIV Infections (HIV Infection)
12/2021 - 11/2021
2Neglected Diseases
06/2020 - 01/2020
1Drug-Related Side Effects and Adverse Reactions
02/2022
1COVID-19
01/2022
1Paracoccidioidomycosis (South American Blastomycosis)
12/2021
1Chagas Disease (American Trypanosomiasis)
12/2021
1Tuberculosis (Tuberculoses)
12/2021
1Leprosy (Hansen's Disease)
12/2021
1Parasitic Diseases (Parasitic Disease)
02/2021
1Heart Diseases (Heart Disease)
01/2021

Drug/Important Bio-Agent (IBA)

19Proteins (Proteins, Gene)FDA Link
06/2022 - 12/2019
8Recombinant ProteinsIBA
06/2022 - 01/2020
6VaccinesIBA
06/2022 - 01/2020
6AntigensIBA
12/2021 - 12/2019
5B-Lymphocyte Epitopes (B-Cell Epitope)IBA
06/2022 - 03/2020
4AntibodiesIBA
01/2022 - 12/2019
3MicellesIBA
07/2022 - 01/2020
3Pyridoxal KinaseIBA
12/2020 - 01/2020
2Recombinant Fusion ProteinsIBA
12/2021 - 08/2021
2Peptides (Polypeptides)IBA
12/2021 - 11/2021
2Immunoglobulin G (IgG)IBA
02/2021 - 01/2020
2Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
02/2021 - 01/2020
2Interleukin-12 (IL 12)IBA
02/2021 - 01/2020
2CardenolidesIBA
01/2021 - 01/2021
2DNA VaccinesIBA
12/2020 - 01/2020
2Synthetic Vaccines (Recombinant Vaccines)IBA
06/2020 - 01/2020
2T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
06/2020 - 01/2020
1SaltsIBA
07/2022
1quinolineIBA
07/2022
1ImmunosorbentsIBA
06/2022
1EnzymesIBA
06/2022
1NaphthoquinonesIBA
02/2022
1Poloxamer (Poloxamer 407)IBA
01/2022
1Guanosine Triphosphate (GTP)IBA
01/2022
1GTP-Binding Proteins (G-Protein)IBA
01/2022
1N 30IBA
12/2021
1EpitopesIBA
11/2021
1AcarboseFDA LinkGeneric
06/2021
1Pharmaceutical PreparationsIBA
02/2021
1Virulence Factors (Pathogenicity Factors)IBA
02/2021
1A-Form DNA (A-DNA)IBA
02/2021
1Ivermectin (Mectizan)FDA Link
02/2021
1SaponinsIBA
02/2021
1miltefosine (Impavido)IBA
01/2021
1DigitoxinFDA Link
01/2021
1Therapeutic UsesIBA
01/2021
1DigitoxigeninIBA
01/2021
1DNA (Deoxyribonucleic Acid)IBA
10/2020
1Liposomes (Liposome)IBA
06/2020
1Leishmania infantum amastin proteinIBA
01/2020
1Peptide Initiation Factors (Initiation Factor)IBA
01/2020
1Clioquinol (Vioform)FDA Link
01/2020
1ProhibitinsIBA
01/2020
1UCON 50-HB-5100 (F127)IBA
01/2020
1NitritesIBA
01/2020
1Staphylococcal Protein A (Protein A)IBA
12/2019

Therapy/Procedure

2Therapeutics
02/2022 - 12/2019
1Aftercare (After-Treatment)
12/2019